(Q39482684)

12 September 2017

1 reference

title

The human interferon-gamma receptor system (English)

1 reference

12 September 2017

Rubinstein M

1

1 reference

PubMed ID

2957306

12 September 2017

Novick D

series ordinal

2

1 reference

PubMed ID

2957306

12 September 2017

Fischer DG

series ordinal

3

1 reference

12 September 2017

1 June 1987

1 reference

12 September 2017

Immunological Reviews

1 reference

12 September 2017

97

1 reference

12 September 2017

29-50

1 reference

The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay

12 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Efficient constitutive production of human fibroblast interferon by hamster cells transformed with the IFN-beta 1 gene fused to an SV40 early promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Molecular cloning and expression of cDNAs for the human interleukin-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

'Non-specific' binding. The problem, and a solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Immune interferon: a pleiotropic lymphokine with multiple effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Constitutive and inducible expression of Ia antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Evidence that types I and II interferons have different receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Antibodies to a cell-surface component coded by human chromosome 21 inhibit action of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Sequence and structural homologies among type I and type II interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Spontaneous production of interferon-gamma and acid-labile interferon-alpha by subpopulations of human mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Structural studies on acid unfolding and refolding of recombinant human interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Type I and Type II interferon receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

Receptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1987.TB00515.X

10.1111/J.1600-065X.1987.TB00515.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

2957306